R&D Dogecoin Cash, Inc. (CBDS) announces a strategic expansion in a fast-growing segment of a meme-monet

March 10, 2025 – Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a publicly traded leader in blockchain innovation, is excited to announce its strategic expansion into the rapidly growing meme coin

Mesquite, NV, May 6, 2025, PayerIdntyLegal, Inc. (OTCQB: CBDS) today announced that Financial Industry Regulatory Authority (FINRA) has published the company's stock dividend on the FINRA Daily List.

The dividend, which was previously declared by the Company and disclosed in accordance with applicable regulations, is set to be paid on May 9, 2025.

This dividend will be distributed in the form of a new class of preferred stock, with one (1) share of preferred stock being awarded for every 1,000 shares of common stock held as of the record date, which was November 25, 2024.

The preferred stock, designated as Series A Preferred and filed with the Nevada Secretary of State on November 13, 2024, carries the right to receive, if and when declared by the Board of Directors, one (1) share of common stock annually per preferred share, provided the holder is of record as of November 25 of the applicable year. The stock is not convertible but may be redeemed by the Company at its discretion on or before October 25, 2034, at a rate of ten (10) shares of common stock for each preferred share.

The symbol for Dogecoin Cash, Inc. common stock will remain CBDS until a new symbol is applied for. A trading symbol for the preferred shares has not yet been assigned. FINRA has indicated that no ex-dividend date will be established for this event.

Fractional shares will be rounded up to one whole share.

About Dogecoin Cash, Inc. (CBDS)

Dogecoin Cash, Inc. (OTCQB: CBDS) is a publicly traded company that owns and operates PrestoDoctor, a trusted leader in medical cannabis telemedicine. CBDS holds the first patented cannabis strain, Ecuadorian Sativa aka “CTA”, and a patented cannabis lozenge for treatment of hypertension. CBDS engages in cannabis product development and licensing, as well as blockchain innovation. The company is actively engaged in leveraging emerging digital assets, decentralized finance (DeFi) solutions, and blockchain technology to enhance its offerings and create new market opportunities.